Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


Cleveland Clinic researchers have discovered a new subtype of multiple sclerosis (MS), providing a better understanding of the individualised nature of the disease. MS has long been characterised as...
In a study, which set out to discover what exercise and physical activity mean to people with multiple sclerosis (MS), researchers identified five key themes. Using a qualitative approach,...
Researchers who recently set out to understand the US public’s views on the risks and benefits of marijuana use have found that Americans view the drug more favourably than existing evidence supports...
Disease-modifying therapies (DMT) are thought to reduce the conversion rate to secondary progressive multiple sclerosis (SPMS). So researchers set out to explore the rate, chronology and contributing...
Scientists who set out to investigate the associations between dietary patterns and risk of a first clinical diagnosis of central nervous system demyelination, a common precursor to multiple...
Argos, Asda, Barclays, Marks & Spencer and Sainsbury’s are just some of the leading high street retailers to have signed up to ‘Purple Tuesday’, the UK’s first ever accessible shopping day. The...
A study, published in the journal Neurology, has revealed that onabotulinumtoxinA (100 U), otherwise known as Botox, can significantly improve urinary incontinence and quality of life in non-...
The Prime Minister has recognised Trishna Bharadia, a well-known MS campaigner and patient advocate, for supporting people living with multiple sclerosis (MS) and other chronic conditions. Trishna is...
A phase 1 study of the potential B-cell targeting oral multiple sclerosis (MS) treatment PRN2246 has shown its ability to cross the human blood brain barrier. The double blind, placebo controlled,...
Depending on the course of multiple sclerosis (MS), quality of life can be affected by a variety of different symptoms. In a study published in the journal Multiple Sclerosis Related Disorders...

Pages